CA2974383C - Systeme et procede pour options de classement pour traitements medicaux - Google Patents

Systeme et procede pour options de classement pour traitements medicaux

Info

Publication number
CA2974383C
CA2974383C CA2974383A CA2974383A CA2974383C CA 2974383 C CA2974383 C CA 2974383C CA 2974383 A CA2974383 A CA 2974383A CA 2974383 A CA2974383 A CA 2974383A CA 2974383 C CA2974383 C CA 2974383C
Authority
CA
Canada
Prior art keywords
processor
patient
drug
efficacy
drug therapies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2974383A
Other languages
English (en)
Other versions
CA2974383A1 (fr
Inventor
Paul G. Ambrose
Sujata Bhavnani
Christopher M. Rubino
Original Assignee
Prxcision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/600,948 external-priority patent/US10534895B2/en
Application filed by Prxcision Inc filed Critical Prxcision Inc
Publication of CA2974383A1 publication Critical patent/CA2974383A1/fr
Application granted granted Critical
Publication of CA2974383C publication Critical patent/CA2974383C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne un système informatique, un produit de programme informatique et un procédé pour déterminer une probabilité d'obtention d'une cible de PK-PD associée à l'efficacité pour un patient qui comprend un processeur obtenant des informations identifiant une infection et, sur la base des informations, générer et afficher, par le processeur, une liste comprenant un ou plusieurs pathogènes cohérents avec les informations, générer une liste comprenant une ou plusieurs thérapies pharmacologiques utilisées pour traiter l'au moins un pathogène. Le procédé comprend en outre l'obtention par le processeur d'informations descriptives associées à un patient et, sur la base des une ou plusieurs thérapies pharmacologiques, la sélection d'un modèle pharmacocinétique et l'application par le processeur du modèle pharmacocinétique et l'utilisation des informations associées au patient pour déterminer, pour chacune des une ou plusieurs thérapies pharmacologiques, une probabilité d'obtention d'une cible de PK-PD associée à l'efficacité pour le patient ayant l'infection.
CA2974383A 2015-01-20 2016-01-20 Systeme et procede pour options de classement pour traitements medicaux Active CA2974383C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/600,948 US10534895B2 (en) 2015-01-20 2015-01-20 System and method for ranking options for medical treatments
US14/600,948 2015-01-20
PCT/US2016/014020 WO2016118562A1 (fr) 2015-01-20 2016-01-20 Système et procédé pour options de classement pour traitements médicaux

Publications (2)

Publication Number Publication Date
CA2974383A1 CA2974383A1 (fr) 2016-07-28
CA2974383C true CA2974383C (fr) 2025-09-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3247463B1 (fr) Système et procédé pour options de classement pour traitements médicaux
Van Deen et al. The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study
Avent et al. Optimising antimicrobial therapy through the use of Bayesian dosing programs
Townsend et al. Procalcitonin-guided antibiotic therapy reduces antibiotic use for lower respiratory tract infections in a United States medical center: results of a clinical trial
Neely Scalpels not hammers: The way forward for precision drug prescription.
US10387617B2 (en) Optimization of medicines delivery
US11521728B2 (en) Optimization of medicines delivery
Placzek et al. Clinical trials with nested subgroups: analysis, sample size determination and internal pilot studies
Hoogeveen et al. A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring
Fleming et al. Review and evaluation of mHealth apps in solid organ transplantation: past, present, and future
US12387828B2 (en) System and method for ranking options for medical treatments
Nowak et al. Group sequential methods for the Mann-Whitney parameter
Chay et al. Cost‐effectiveness of a multicomponent primary care intervention for hypertension
Varghese et al. Cost-effectiveness of add-on empagliflozin versus standard of care in management of CKD in Malaysia, Thailand and Vietnam–findings from a modelling study assessing an EMPA-KIDNEY eligible population, using CKD progression model
Rive et al. Cost effectiveness of memantine in Alzheimer's disease in the UK
Mastrorilli et al. Cost analysis of platelet transfusion in Italy for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures
CA2974383C (fr) Systeme et procede pour options de classement pour traitements medicaux
Ascher-Svanum et al. Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia
Heller et al. Prioritising between direct observation of therapy and case-finding interventions for tuberculosis: use of population impact measures
Gao et al. Estimating risk factor time paths among people with type 2 diabetes and QALY gains from risk factor management
Owens Jr et al. Pharmacokinetics–pharmacodynamics, computer decision support technologies, and antimicrobial stewardship: The compass and rudder
Dasta et al. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia
Chopra et al. Cost-effectiveness of aripiprazole tablets with sensor versus oral atypical antipsychotics for the treatment of schizophrenia using a patient-level microsimulation modeling approach
Li et al. Optimizing implementation of hepatitis C birth-cohort screening and treatment strategies: model-based projections
US20220415514A1 (en) Asymptomatic complex disease monitoring engine